FBT vs. IBB
FBT (First Trust Amex Biotechnology Index) and IBB (iShares Nasdaq Biotechnology ETF) are both Health & Biotech Equities funds - FBT tracks the NYSE Arca Biotechnology Index while IBB tracks the NASDAQ Biotechnology Index. Both are passively managed. Over the past 10 years, FBT returned 10.45%/yr vs 8.14%/yr for IBB. Their correlation of 0.92 suggests significant overlap in exposure. FBT charges 0.57%/yr vs 0.47%/yr for IBB.
Performance
FBT vs. IBB - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, FBT achieves a 11.27% return, which is significantly higher than IBB's 4.97% return. Over the past 10 years, FBT has outperformed IBB with an annualized return of 10.45%, while IBB has yielded a comparatively lower 8.14% annualized return.
FBT
- 1D
- 0.41%
- 1M
- 7.91%
- YTD
- 11.27%
- 6M
- 6.83%
- 1Y
- 44.08%
- 3Y*
- 13.78%
- 5Y*
- 6.30%
- 10Y*
- 10.45%
IBB
- 1D
- 1.94%
- 1M
- 4.88%
- YTD
- 4.97%
- 6M
- 2.54%
- 1Y
- 41.38%
- 3Y*
- 11.58%
- 5Y*
- 2.25%
- 10Y*
- 8.14%
FBT vs. IBB - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FBT First Trust Amex Biotechnology Index | 11.27% | 24.25% | 5.88% | 2.55% | -4.83% | -2.26% | 12.96% | 19.74% | -0.30% | 37.07% |
IBB iShares Nasdaq Biotechnology ETF | 4.97% | 27.98% | -2.41% | 3.76% | -13.69% | 0.95% | 26.01% | 25.42% | -9.53% | 21.08% |
Correlation
The correlation between FBT and IBB is 0.91, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.91 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.92 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.93 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.93 |
Correlation (All Time) Calculated using the full available price history since Jun 23, 2006 | 0.92 |
The correlation between FBT and IBB has been stable across timeframes, ranging from 0.91 to 0.93 - a consistent structural relationship.
FBT vs. IBB - Sectors Allocation Comparison
Sectors
FBT
IBB
Healthcare
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
FBT
IBB
Basic Materials
FBT
-
IBB
-
Communication Services
FBT
-
IBB
-
Consumer Cyclical
FBT
-
IBB
-
Consumer Defensive
FBT
-
IBB
-
Energy
FBT
-
IBB
-
Financial Services
FBT
-
IBB
-
Industrials
FBT
-
IBB
-
Real Estate
FBT
-
IBB
-
Technology
FBT
-
IBB
-
Utilities
FBT
-
IBB
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
FBT vs. IBB — Risk / Return Rank
FBT
IBB
FBT vs. IBB - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for First Trust Amex Biotechnology Index (FBT) and iShares Nasdaq Biotechnology ETF (IBB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| FBT | IBB | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.06 | ||
| Sortino ratioReturn per unit of downside risk | +0.14 | ||
| Omega ratioGain probability vs. loss probability | 1.36 | 1.34 | +0.02 |
| Calmar ratioReturn relative to maximum drawdown | 3.11 | 4.32 | -1.21 |
| Martin ratioReturn relative to average drawdown | 9.19 | 13.28 | -4.10 |
Loading charts...
Drawdowns
FBT vs. IBB - Drawdown Comparison
The maximum FBT drawdown since its inception was -40.51%, smaller than the maximum IBB drawdown of -62.85%. Use the drawdown chart below to compare losses from any high point for FBT and IBB.
Loading charts...
Drawdown Indicators
| FBT | IBB | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -40.51% | -62.85% | +22.34% |
Max Drawdown (1Y)Largest decline over 1 year | -14.26% | -9.63% | -4.63% |
Max Drawdown (3Y)Largest decline over 3 years | -20.05% | -24.85% | +4.80% |
Max Drawdown (5Y)Largest decline over 5 years | -28.98% | -39.82% | +10.84% |
Max Drawdown (10Y)Largest decline over 10 years | -32.37% | -39.82% | +7.45% |
Current DrawdownCurrent decline from peak | 0.00% | -0.27% | +0.27% |
Average DrawdownAverage peak-to-trough decline | -11.14% | -21.15% | +10.01% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.81% | 3.12% | +1.69% |
Volatility
FBT vs. IBB - Volatility Comparison
The current volatility for First Trust Amex Biotechnology Index (FBT) is 6.54%, while iShares Nasdaq Biotechnology ETF (IBB) has a volatility of 6.96%. This indicates that FBT experiences smaller price fluctuations and is considered to be less risky than IBB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| FBT | IBB | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.54% | 6.96% | -0.42% |
Volatility (6M)Calculated over the trailing 6-month period | 16.15% | 15.99% | +0.16% |
Volatility (1Y)Calculated over the trailing 1-year period | 21.06% | 20.37% | +0.69% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.88% | 22.03% | -0.15% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.88% | 23.22% | +0.66% |
FBT vs. IBB - Expense Ratio Comparison
FBT has a 0.57% expense ratio, which is higher than IBB's 0.47% expense ratio.
Dividends
FBT vs. IBB - Dividend Comparison
FBT has not paid dividends to shareholders, while IBB's dividend yield for the trailing twelve months is around 0.23%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FBT First Trust Amex Biotechnology Index | 0.00% | 0.00% | 0.71% | 0.00% | 0.00% | 1.37% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.12% |
IBB iShares Nasdaq Biotechnology ETF | 0.23% | 0.23% | 0.29% | 0.26% | 0.31% | 0.21% | 0.21% | 0.33% | 0.20% | 0.30% | 0.19% | 0.03% |
Frequently Asked Questions
With a correlation of 0.91, FBT and IBB move almost identically. Holding both adds very little diversification - you're essentially doubling your position in the same market segment. Choosing one is usually more capital-efficient.
IBB has higher volatility (6.96%) compared to FBT (6.54%). In terms of maximum drawdown, FBT dropped -40.51% vs IBB's -62.85%.
On 10-year performance, FBT leads with 10.45% vs 8.14% for IBB. On fees, IBB is cheaper at 0.47% per year. On volatility, FBT has been the lower-risk option at 6.54%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, FBT has performed better with a 10.45% return vs 8.14%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
IBB is cheaper with a 0.47% expense ratio, compared with 0.57% for FBT.
IBB has the higher dividend yield at 0.23%, compared with 0.00% for FBT.
FBT tracks NYSE Arca Biotechnology Index, while IBB tracks NASDAQ Biotechnology Index. They also come from different issuers: First Trust and iShares. Their fees differ too: 0.57% for FBT and 0.47% for IBB.
FBT currently has the higher Sharpe Ratio (2.11 vs 2.05), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for FBT and IBB
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer